Brachytherapy appears to have significant advantages over EBRT in the treatment of men with low-risk and intermediate-risk prostate cancer. John Schieszer reports in today’s Medical Minute that new data from the Cleveland Clinic suggest that brachytherapy may be underused.

Topics:

Brachytherapy Prostate Cancer